spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BioPharm America™ 2017—10th Annual International Partnering Conference

BioPharm America™ 2017—10th Annual International Partnering Conference

26-27 September 2017
39 Dalton Street, Boston, MA 02116

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Now in its tenth year, BioPharm America creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size and stage, from mature to startup. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.

A primary focus of BioPharm America™ is the one-to-one meetings driven by partneringONE®, the industry’s most robust software platform. Delegates can request and schedule meetings tailored to their strategic business goals to create a dynamic personalized agenda that includes regular alerts for further meeting opportunities.
The impetus behind this intensive business development activity is a two-day conference program that features thought leaders and executives from across the life science industry. To help bring attention to early stage projects and small entrepreneurial companies, BioPharm America features special tracks specifically designed for startups and young companies to get on the radar of the global life science community and to make the connections that matter. Engaging panel discussions cover topics of interest to dealmakers including licensing, investment and business development.

Leading pharmaceutical companies attend BioPharm America in search of innovation, such as Amgen, AstraZeneca, Bayer HealthCare, Biogen Idec, Boehringer Ingelheim, Genentech, Sanofi/Genzyme, Gilead, Ironwood, Johnson & Johnson Innovation, Merck, Novo Nordisk, Nycomed, Pfizer, and Shire. Held in Boston each September, the event attracted 850+ delegates from 525 companies who participated in 2,350+ scheduled one-to-one meetings in 2016.

For more information and online registration please visit our conference website at https://ebdgroup.knect365.com/biopharm-america

Producer:
EBD Group, Inc.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

Contact:
Cassidy Hamilton
EBD Group
Carlsbad, CA
+1 760 930 0500
chamilton@ebdgroup.com

Industry:
Biotech

Key words:
partnering, early stage, investing, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance
Intended for:

Top international executives from:

    Established and emerging biotech companies
    Pharmaceutical companies
    Institutional financial firms
    Private investors including venture capital and private equity firms
    Startup Biotech Companies (via Startup program)
    Scientists / Researches (via Charles River Track)


Speakers:
https://ebdgroup.knect365.com/biopharm-america/speakers

Cost:
https://ebdgroup.knect365.com/biopharm-america/registration-information

Program:
https://ebdgroup.knect365.com/biopharm-america/agenda/1
phone Cassidy Hamilton: +1 760 930 0500
email Cassidy Hamilton: chamilton@ebdgroup.com
web bit.ly/2rTMm4G
email 39 Dalton Street, Boston, MA 02116
 
Print this page
Send to a friend
   
spacer
Industry Events

5th Biennial Biosimilars & Biobetters Congress 2018

16-17 April 2018, Novotel London West Hotel, Hammersmith, London

Oxford Global are proud to present our highly anticipated 5thBiennial Biosimilars & Biobetters Congress, 16th – 17thApril 2018, London, UK. Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions will enjoy over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics
More info >>

Banner of Clinical_Trial_New_England_events_95 on Samedan Banner of 3D_Cell_Culture_events_97 on Samedan

White Papers

Soothing the Logistical Headache of Clinical Trials

Equilibrium Travel Management

As many as 30 per cent of subjects on phase three clinical studies drop out.  Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial.  It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
More info >>


News and Press Releases

Charles River Announces Success of Integrated Discovery Project with ENYO Pharma

Wilmington, Mass and Lyon, France, Nov. 28, 2017 - Charles River Laboratories International, Inc. (NYSE: CRL) and ENYO Pharma SA today announced the results of a successful collaboration. Together, the companies identified the mode of action of ENYO Pharma’s lead preclinical chemical series, EYP002, using Charles River’s newly acquired, molecular target identification tool: Capture Compound Mass Spectrometry (CCMS) technology.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement